Trial
NCT02994251
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Unresectable Intrahepatic Cholangiocarcinoma
Intervention
gemcitabine
Why stopped
Study terminated due to low enrollment making it unlikely to meet recruitment goals.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-30